Agomab News, Agomab Quote, AGMB Quote

Agomab (NQ:AGMB) Delayed: 9.15 +0.42 (4.81%)

Prev. Close

$8.73

Today 6M 1Y 5Y

Open

$8.74

52 Wk High

$0.01

52 Wk Low

$0.01

Day High

$9.22

Day Low

$8.74

P/E

N/A

EPS

$0.00

Volume

30,365

Friends, Peers and Foes (?): CRSP DNTH (more...)

ALERTS | RSS

Oct 21, 2026 06:51 AM H.C. Wainwright Reiterates Buy Rating on Agomab Therapeutics (AGMB)
Oct 13, 2026 05:19 PM Form 6-K AgomAb Therapeutics NV For: Oct 13
Oct 13, 2026 04:05 PM Agomab doses first patient in Phase 2b Crohn's disease study
Oct 13, 2026 04:05 PM Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
Oct 9, 2026 08:01 AM Form 4 AgomAb Therapeutics NV For: Oct 08 Filed by: Epstein David R
Oct 7, 2026 08:57 AM Form 4 AgomAb Therapeutics NV For: Oct 05 Filed by: Epstein David R
Oct 7, 2026 08:47 AM Form 4 AgomAb Therapeutics NV For: Oct 06 Filed by: Kemula Pierre Thadee Victor
Oct 7, 2026 08:07 AM Form 4 AgomAb Therapeutics NV For: Oct 05 Filed by: Knotnerus Tim Jasper
Oct 2, 2026 06:59 AM H.C. Wainwright Reiterates Buy Rating on Agomab Therapeutics (AGMB)
Oct 1, 2026 09:05 AM Agomab stock jumps on positive trial data

Entities mentioned with AGMB

View All Entities